Jim Cramer’s Game Plan: 15 Stocks in Focus

13. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 106

Cramer, a long-time admirer of Eli Lilly and Company (NYSE:LLY), commented:

“Thursday, more drugs. Yes, this is a tough drug week. Aforementioned Eli Lilly reports while CEO David Ricks announced here on CNBC that 2025 will be a good year, we gotta get some more details before we plow in. I remain steadfast. We have a big position for the trust… If you do get good news from Novo Nordisk, get this, you might wanna buy some Eli Lilly before it reports on Thursday.”

Eli Lilly (NYSE:LLY) is dedicated to the discovery, development, and marketing of a variety of pharmaceutical products, including treatments for diabetes, cancer, autoimmune diseases, pain, and migraines. Recently, during a Mad Money episode, Cramer stated:

“Okay, so I mean we just found out today that Ozempic has something for kidney failure and that means that maybe Lily has it. Now Lilly has, I will say this, the single worst chart I have seen in a long time and there are a lot of people on Wall Street, are chartists. However, I actually like the fundamentals. Now, David Ricks did on our show, preannounce a better-than-expected quarter and nobody listened. But I do believe in Lilly, we own it for the trust, and I’ve gotta tell you, I think in another dip, you get another opportunity to buy and I’m sticking by that.”